Reversible sensorineural hearing loss following administration of muromonab-CD3 (OKT3) for cadaveric renal transplant immunosuppression

Christopher J. Hartnick, Richard V. Smith, Stuart Greenstein, Vivian Tellis, Robert J. Ruben

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Reversible sensorineural hearing loss following administration of muromonab-CD3 (OKT3) for cadaveric renal transplant immunosuppression'. Together they form a unique fingerprint.

Medicine & Life Sciences